STAT
MARCH 18, 2023
Doctors and investors are getting their first glimpse of the data that compelled Takeda Pharmaceutical to make a $6 billion bet on an experimental pill. The drug, which it acquired from Boston biotech Nimbus Therapeutics last month, blocks a key lever in the immune system that Takeda believes has the potential to treat numerous autoimmune and inflammatory diseases.
Drug Store News
MARCH 18, 2023
Pain Care Labs offers Buzzy and VibraCool for relief of needle pain and other aches.
The Guardian - Pharmaceutical Industry
MARCH 18, 2023
Pharmaceutical company behind blockbuster diet jab Wegovy confronts crises on multiple fronts, amid scrutiny of UK activities The maker of slimming jab Wegovy was facing crises on multiple fronts this weekend, with the UK medicines regulator announcing a review of its operations at the same time as an investigation is under way into the approval of its injections for NHS use.
Expert insights. Personalized for you.
106 
Let's personalize your content